UBP Greater China (Shanghai) Co., Ltd

Quick facts

Phase 2 pipeline

• UB-621 high-dose
• UB-621 low-dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• UBP Greater China (Shanghai) Co., Ltd portfolio CI brief
• UBP Greater China (Shanghai) Co., Ltd pipeline updates RSS

Related

• Sector hub: All tracked pharma companies